ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 67
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
IssuerBlackrock
ETF TickerBTEE(USD) LSE
ETF TickerBTEE.L(GBP) LSE

Holdings detail for AVIR

Stock NameAtea Pharmaceuticals Inc
TickerAVIR(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS04683R1068

Show aggregate AVIR holdings

News associated with AVIR

Atea Pharmaceuticals (NASDAQ:AVIR) Rating Lowered to “Sell” at Wall Street Zen
Atea Pharmaceuticals (NASDAQ:AVIR – Get Free Report) was downgraded by equities research analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research report issued on Saturday. Separately, Morgan Stanley decreased their price objective on Atea Pharmaceuticals from $6.20 to $6.00 and set an “equal weight” rating on the stock […] - 2025-08-11 03:58:51
Two Sigma Advisers LP Sells 88,800 Shares of Atea Pharmaceuticals, Inc. (NASDAQ:AVIR)
Two Sigma Advisers LP lessened its position in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR – Free Report) by 15.2% in the 4th quarter, Holdings Channel.com reports. The fund owned 493,600 shares of the company’s stock after selling 88,800 shares during the period. Two Sigma Advisers LP’s holdings in Atea Pharmaceuticals were worth $1,654,000 at the end of […] - 2025-05-30 05:34:49
96,433 Shares in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Purchased by BNP Paribas Financial Markets
BNP Paribas Financial Markets acquired a new position in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR – Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 96,433 shares of the company’s stock, valued at approximately $323,000. Several other institutional investors also recently bought and sold shares […] - 2025-05-27 04:38:55
Graham Capital Management L.P. Buys Shares of 12,511 Atea Pharmaceuticals, Inc. (NASDAQ:AVIR)
Graham Capital Management L.P. bought a new stake in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 12,511 shares of the company’s stock, valued at approximately $42,000. A number of other hedge […] - 2025-05-20 05:09:23
Dimensional Fund Advisors LP Increases Holdings in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR)
Dimensional Fund Advisors LP lifted its position in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR – Free Report) by 23.2% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 977,470 shares of the company’s stock after purchasing an additional 183,844 shares during the period. Dimensional Fund Advisors LP’s holdings […] - 2025-05-14 04:36:48
Barclays PLC Raises Stock Holdings in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR)
Barclays PLC lifted its holdings in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR – Free Report) by 13.0% in the fourth quarter, HoldingsChannel reports. The firm owned 200,113 shares of the company’s stock after purchasing an additional 23,036 shares during the quarter. Barclays PLC’s holdings in Atea Pharmaceuticals were worth $671,000 at the end of the most recent […] - 2025-05-08 04:36:45
Marshall Wace LLP Buys New Shares in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR)
Marshall Wace LLP purchased a new position in shares of Atea Pharmaceuticals, Inc. (NASDAQ:AVIR – Free Report) during the 4th quarter, HoldingsChannel reports. The firm purchased 77,581 shares of the company’s stock, valued at approximately $260,000. A number of other hedge funds also recently bought and sold shares of the stock. Barclays PLC increased its […] - 2025-05-05 05:05:05
Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Stock Position Raised by Federated Hermes Inc.
Federated Hermes Inc. boosted its position in shares of Atea Pharmaceuticals, Inc. (NASDAQ:AVIR – Free Report) by 1.9% during the 4th quarter, HoldingsChannel reports. The firm owned 582,939 shares of the company’s stock after buying an additional 10,856 shares during the quarter. Federated Hermes Inc.’s holdings in Atea Pharmaceuticals were worth $1,953,000 at the end […] - 2025-04-14 05:15:06

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) AVIR holdings

DateNumber of AVIR Shares HeldBase Market Value of AVIR SharesLocal Market Value of AVIR SharesChange in AVIR Shares HeldChange in AVIR Base ValueCurrent Price per AVIR Share HeldPrevious Price per AVIR Share Held
2026-02-09 (Monday)62,479USD 258,663USD 258,663
2026-02-06 (Friday)62,341AVIR holding increased by 138USD 258,715AVIR holding increased by 5549USD 258,715138USD 5,549 USD 4.15 USD 4.07
2026-02-02 (Monday)62,203USD 253,166AVIR holding decreased by -10575USD 253,1660USD -10,575 USD 4.07 USD 4.24
2026-01-30 (Friday)62,203AVIR holding increased by 278USD 263,741AVIR holding increased by 21614USD 263,741278USD 21,614 USD 4.24 USD 3.91
2026-01-29 (Thursday)61,925AVIR holding increased by 139USD 242,127AVIR holding decreased by -9342USD 242,127139USD -9,342 USD 3.91 USD 4.07
2026-01-27 (Tuesday)61,786AVIR holding increased by 139USD 251,469AVIR holding increased by 4881USD 251,469139USD 4,881 USD 4.07 USD 4
2026-01-26 (Monday)61,647USD 246,588AVIR holding decreased by -7398USD 246,5880USD -7,398 USD 4 USD 4.12001
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of AVIR by Blackrock for IE00BDZVHG35

Show aggregate share trades of AVIR

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2026-02-06BUY138 4.150* -
2026-01-30BUY2784.3053.840 3.886USD 1,080 -
2026-01-29BUY1393.9353.769 3.785USD 526 -
2026-01-27BUY1394.1503.930 3.952USD 549 -
2026-01-23BUY2784.3403.620 3.692USD 1,026 -
2026-01-22BUY1393.6703.530 3.544USD 493 -
2026-01-15BUY2863.6353.440 3.460USD 989 -
2026-01-14BUY2863.5553.440 3.452USD 987 -
2026-01-12BUY2863.6403.390 3.415USD 977 -
2026-01-09BUY4293.6703.430 3.454USD 1,482 -
2026-01-07BUY2863.5303.340 3.359USD 961 -
2026-01-02BUY1433.5603.410 3.425USD 490 -
2025-12-30BUY1433.5903.520 3.527USD 504 -
2025-12-23SELL-1,7403.4403.190 3.215USD -5,594 -
2025-12-17SELL-7253.2663.160 3.171USD -2,299 -
2025-12-16SELL-1453.2603.135 3.147USD -456 -
2025-12-15BUY2903.1803.110 3.117USD 904 -
2025-12-11BUY2903.2303.141 3.150USD 913 -
2025-12-04BUY2,9003.1253.030 3.039USD 8,815 -
2025-12-02BUY2,1603.0802.995 3.003USD 6,488 -
2025-11-28BUY1443.1003.005 3.015USD 434 -
2025-11-26BUY4323.0703.010 3.016USD 1,303 -
2025-11-26BUY4323.0703.010 3.016USD 1,303 -
2025-11-25BUY7203.0602.960 2.970USD 2,138 -
2025-11-24BUY1443.0252.960 2.967USD 427 -
2025-11-20SELL-5763.1802.985 3.004USD -1,731 -
2025-11-19BUY1443.1652.980 2.999USD 432 -
2025-11-18BUY8643.0652.975 2.984USD 2,578 -
2025-11-17BUY2883.0452.920 2.933USD 845 -
2025-11-14BUY1443.0502.895 2.910USD 419 -
2025-11-12BUY1433.5003.325 3.343USD 478 -
2025-11-10BUY1433.3553.250 3.261USD 466 -
2025-11-06BUY1433.2603.180 3.188USD 456 -
2025-11-04BUY1443.2373.180 3.186USD 459 -
2025-10-30BUY7203.3353.215 3.227USD 2,323 -
2025-10-29BUY2883.2903.315 3.313USD 954 -
2025-10-22SELL-5683.2803.297 3.295USD -1,872 -
2025-10-20BUY2843.2203.225 3.224USD 916 -
2025-10-17BUY7083.0603.120 3.114USD 2,205 -
2025-10-15BUY1,1203.1503.174 3.172USD 3,552 -
2025-10-03BUY1,0082.9002.920 2.918USD 2,941 -
2025-10-02BUY1442.8202.880 2.874USD 414 -
2025-09-30BUY2882.9002.919 2.917USD 840 -
2025-09-26BUY2882.9302.950 2.948USD 849 -
2025-09-25BUY2882.9102.915 2.914USD 839 -
2025-09-18BUY1432.9703.000 2.997USD 429 -
2025-09-17BUY4292.9103.000 2.991USD 1,283 -
2025-07-17SELL-2823.4603.525 3.519USD -992 -
2025-07-11SELL-1,1443.6703.790 3.778USD -4,322 -
2025-07-02BUY7,8653.6253.800 3.782USD 29,749 -
2025-06-25BUY2843.4703.510 3.506USD 996 -
2025-06-11BUY2863.1753.305 3.292USD 942 -
2025-06-10BUY2863.2203.345 3.333USD 953 -
2025-06-04SELL-1433.2303.277 3.272USD -468 -
2025-04-23BUY1432.8502.955 2.944USD 421 -
2025-04-10SELL-1,1442.6902.710 2.708USD -3,098 -
2025-04-08SELL-1432.6502.890 2.866USD -410 -
2025-04-07SELL-1432.7802.910 2.897USD -414 -
2025-04-04SELL-7152.7902.985 2.965USD -2,120 -
2025-04-01BUY5722.8502.975 2.962USD 1,695 -
2025-03-31SELL-4292.9903.025 3.022USD -1,296 -
2025-03-14SELL-2,2883.0803.105 3.103USD -7,099 -
2025-03-07SELL-2862.9903.050 3.044USD -871 -
2025-03-04SELL-1432.9003.020 3.008USD -430 -
2025-02-25BUY2863.1403.170 3.167USD 906 -
2025-02-19SELL-1433.0903.140 3.135USD -448 -
2025-02-13BUY4293.1103.178 3.171USD 1,360 -
2025-02-12BUY1433.1103.205 3.195USD 457 -
2025-02-11BUY5722.9903.075 3.067USD 1,754 -
2024-12-30SELL-7153.3303.380 3.375USD -2,413 -
2024-11-18SELL-2,1453.1703.315 3.301USD -7,080 -
2024-11-08SELL-1433.5003.570 3.563USD -510 -
2024-10-21SELL-1433.5903.860 3.833USD -548 -
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of AVIR

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-1927,136044,28961.3%
2025-09-1826,8491,70094,86328.3%
2025-09-1754,1600112,73948.0%
2025-09-1618,331044,57041.1%
2025-09-1535,397069,53850.9%
2025-09-1225,254041,70660.6%
2025-09-1147,90690670,30068.1%
2025-09-1029,879082,10636.4%
2025-09-0916,999030,28356.1%
2025-09-0825,73610845,77956.2%
2025-09-0527,390046,44359.0%
2025-09-048,330041,19820.2%
2025-09-0328,626050,88056.3%
2025-09-0229,258048,12260.8%
2025-08-2914,641034,62142.3%
2025-08-2819,740058,85033.5%
2025-08-2728,119055,43350.7%
2025-08-2633,203061,80653.7%
2025-08-2562,709096,28465.1%
2025-08-22127,4030179,44271.0%
2025-08-2169,351078,09488.8%
2025-08-2058,020070,87181.9%
2025-08-19141,0830180,27878.3%
2025-08-1879,540099,67679.8%
2025-08-1528,4590114,11124.9%
2025-08-1462,063072,45185.7%
2025-08-1356,642091,41062.0%
2025-08-1257,895077,43574.8%
2025-08-1154,561089,40061.0%
2025-08-0863,1500116,05254.4%
2025-08-0795,2360116,75781.6%
2025-08-0657,70362490,54763.7%
2025-08-0551,732078,46565.9%
2025-08-0440,6590105,64338.5%
2025-08-0134,936099,46135.1%
2025-07-3120,101061,75132.6%
2025-07-3018,150094,41419.2%
2025-07-2928,301669,47540.7%
2025-07-2821,355066,63132.0%
2025-07-2524,3594,090104,34223.3%
2025-07-2424,9267,282124,12020.1%
2025-07-2371,720211180,67939.7%
2025-07-2211,409093,37812.2%
2025-07-2127,1400105,82125.6%
2025-07-1828,86756773,45839.3%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy